Two case reports of skin vasculitis following the COVID-19 immunization-Reference-Cited by-同舟云学术

Two case reports of skin vasculitis following the COVID-19 immunization

Published:2022-01-01 Issue:1 Volume:17 Page:1944-1948
ISSN:2391-5463
Container-title:Open Medicine
language:en
Short-container-title:

Author:

Chomičienė Anželika¹,Černiauskas Kęstutis¹,Linauskienė Kotryna¹²,Meškauskas Raimundas³,Malinauskienė Laura¹

Affiliation:

1. Vilnius University, Medical Faculty, Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Department of Pulmonology and Allergology , Vilnius , Lithuania

2. Vilnius University Hospital Santaros Klinikos, Department of Pulmonology and Allergology , Santariškių Str. 2 , Vilnius LT-08661 , Lithuania

3. Pathology Department, National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos , Vilnius , Lithuania

Abstract

Abstract The coronavirus 2019 (COVID-19) disease is now responsible for one of the most challenging and concerning pandemics. Since December 2020, the world has had access to COVID-19 prophylaxis; thus, we encounter adverse events from vaccination more often due to the vast vaccination range. We present two case reports of difficult-to-treat skin vasculitis due to COVID-19 vaccination that were successfully treated in a tertiary-level university hospital. When encountering systemic treatment, resistant skin vasculitis plasmapheresis could be a choice of treatment.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/med-2022-0608/pdf

Reference15 articles.

1. Council for International Organizations of Medical Sciences (CIOMS). Definition and application of terms for vaccine pharmacovigilance: report of CIOMS/WHO Working Group on Vaccine Pharmacovigilance. Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2012.

2. Gupta A, Madhavan MV, Seghal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–32.

3. Gisondi P, Piaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical update. JEADV. 2020;34(11):2499–504.

4. Bouaziz JD, Duong TA, Jachiet M, Velter C, Lestang P, Cassius C, et al. Vascular skin symptoms in COVID-19: a French observational study. JEADV. 2020;34:e433–531.

5. Novak N, Peng W, Naegeli MC, Galvan C, Kolm-Djamei I, Brüggen C, et al. SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far? Allergy. 2021;76:698–713.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review;Vaccines;2023-10-08

2. Multiple drugs;Reactions Weekly;2023-01-14